Table 1: Clinical characteristics of 45 liver cirrhosis patients with HCC.

Dose of sorafenib200 mg400 mg800 mg

No. of patients11277
Mean age72.1 ± 769.4 ± 666.1 ± 7
Gender (M/F)7/424/37/0
Type of cirrhosis
(HBV/HCV/non B non C)
1/8/25/17/52/1/4
Child-Pugh classification
(A/B/C)
8/3/026/1/05/2/0
Stage
(III/IVAIIVB)
0/9/21/24/20/7/0
JIS score
(2/3/4/5)
0/8/3/00/26/1/00/5/2/0